Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Konkret geht es um den Diabetes-Patienten mit kardiovaskulären Erkrankungen oder Risiken, die Herzinsuffizienz sowie die kardiovaskuläre Primär- und Sekundärprävention. Sind Sie hier schon auf dem neuesten Stand? Unsere Experten beleuchten, wo und warum das bisherige Procedere geändert werden soll und was in der Praxis sinnvoll ist. Holen Sie sich Ihr Update und 2 CME-Punkte beim MMW-Webinar am 24. April von 17.30 bis 19 Uhr. 
Erweiterte Suche
Anmelden
nach oben
Inflammation
Erschienen in: Inflammation 1/2020

11.07.2019 | Review

Oxidant/Antioxidant Disequilibrium in Idiopathic Pulmonary Fibrosis Pathogenesis

verfasst von: Paolo Cameli, Alfonso Carleo, Laura Bergantini, Claudia Landi, Antje Prasse, Elena Bargagli

Erschienen in: Inflammation | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Abstract

Idiopathic pulmonary fibrosis is characterised by abnormal reepithelialisation and remodelling consequent to persistent stimuli or injury. The involvement of oxidative stress in alveolar injury, inflammation and fibrosis development has been suggested. Increased concentrations of lipid peroxidation products, oxidised proteins and an altered antioxidant enzyme status with the depletion of glutathione, the most abundant low-molecular-weight antioxidant, have often been reported in epithelial lining fluid of IPF patients. This review describes the sources of free radical generation, ROS-induced signalling pathways and mechanisms of oxidative stress damages in the pathogenesis of idiopathic pulmonary fibrosis.
Literatur
1.
Cottin, V., F. Capron, P. Grenier, and J.F. Cordier. 2004. Diffuse idiopathic interstitial pneumonias, international multidisciplinary consensus classification by the American Thoracic Society and the European Respiratory Society, principal clinico-pathological entities, and diagnosis. Revue des Maladies Respiratoires 21 (2 Pt 1): 299–318.PubMed
2.
Raghu, G., H.R. Collard, J.J. Egan, F.J. Martinez, J. Behr, K.K. Brown, T.V. Colby, J.F. Cordier, K.R. Flaherty, J.A. Lasky, D.A. Lynch, J.H. Ryu, J.J. Swigris, A.U. Wells, J. Ancochea, D. Bouros, C. Carvalho, U. Costabel, M. Ebina, D.M. Hansell, T. Johkoh, D.S. Kim, King te Jr, Y. Kondoh, J. Myers, N.L. Müller, A.G. Nicholson, L. Richeldi, M. Selman, R.F. Dudden, B.S. Griss, S.L. Protzko, H.J. Schünemann, and ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis. 2011. An official ATS/ERS/JRS/ALAT statement: Idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. American Journal of Respiratory and Critical Care Medicine 183: 788–824.PubMedPubMedCentral
3.
Nalysnyk, L., J. Cid-Ruzafa, P. Rotella, and D. Esser. 2012. Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literature. European Respiratory Review 21: 355–361.PubMed
4.
Fois, A.G., P. Paliogiannis, S. Sotgia, A.A. Mangoni, E. Zinellu, P. Pirina, C. Carru, and A. Zinellu. 2018. Evaluation of oxidative stress biomarkers in idiopathic pulmonary fibrosis and therapeutic applications: a systematic review. Respiratory Research 19 (1): 51.PubMedPubMedCentral
5.
Johannson, K.A., J.R. Balmes, and H.R. Collard. 2015. Air pollution exposure: a novel environmental risk factor for interstitial lung disease? Chest 147 (4): 1161–1167.PubMedPubMedCentral
6.
Raghu, G., B. Rochwerg, Y. Zhang, C.A. Garcia, A. Azuma, J. Behr, J.L. Brozek, H.R. Collard, W. Cunningham, S. Homma, T. Johkoh, F.J. Martinez, J. Myers, S.L. Protzko, L. Richeldi, D. Rind, M. Selman, A. Theodore, A.U. Wells, H. Hoogsteden, H.J. Schünemann, and American Thoracic Society., European Respiratory society., Japanese Respiratory Society., Latin American Thoracic Association. 2015. An official ATS/ERS/JRS/ALAT clinical practice guideline: treatment of idiopathic pulmonary fibrosis. American Journal of Respiratory and Critical Care Medicine 192: e3–e19.PubMed
7.
Hilberg, O., U. Simonsen, R. du Bois, and E. Bendstrup. 2012. Pirfenidone: significant treatment effects in idiopathic pulmonary fibrosis. The Clinical Respiratory Journal 6 (3): 131–143.PubMed
8.
Wollin, L., I. Maillet, V. Quesniaux, A. Holweg, and B. Ryffel. 2014. Antifibrotic and anti-inflammatory activity of the tyrosine kinase inhibitor nintedanib in experimental models of lung fibrosis. The Journal of Pharmacology and Experimental Therapeutics 349 (2): 209–220.PubMed
9.
Magi, B., E. Bargagli, L. Bini, and P. Rottoli. 2006. Proteome analysis of bronchoalveolar lavage in lung diseases. Proteomics. 6: 6354–6369.PubMed
10.
Rottoli, P., B. Magi, M.G. Perari, S. Liberatori, N. Nikiforakis, E. Bargagli, R. Cianti, L. Bini, and V. Pallini. 2005. Cytokine profile and proteome analysis in BAL of patients with sarcoidosis, pulmonary fibrosis associated with systemic sclerosis and idiopathic pulmonary fibrosis. Proteomics. 5: 1423–1430.PubMed
11.
Ahmad, S., M.Y. Khan, Z. Rafi, H. Khan, Z. Siddiqui, S. Rehman, U. Shahab, M.S. Khan, M. Saeed, S. Alouffi, and M.S. Khan. 2018. Oxidation, glycation and glycoxidation - the vicious cycle and lung cancer. Seminars in Cancer Biology 49: 29–36.PubMed
12.
Gawda, A., G. Majka, B. Nowak, et al. 2017. Air pollution, oxidative stress, and exacerbation of autoimmune diseases. Central-European Journal of Immunology 42 (3): 305–312.PubMedPubMedCentral
13.
Gonzalez-Gonzalez, F.J., N.S. Chandel, M. Jain, and G.R.S. Budinger. 2017. Reactive oxygen species as signaling molecules in the development of lung fibrosis. Translational Research 190: 61–68.PubMedPubMedCentral
14.
Ferrari, R.S., and C.F. Andrade. 2015. Oxidative stress and lung ischemia-reperfusion injury. Oxidative Medicine and Cellular Longevity 2015: 590987.PubMedPubMedCentral
15.
Chanda, D., E. Otoupalova, S.R. Smith, T. Volckaert, S.P. De Langhe, and V.J. Thannickal. 2019. Developmental pathways in the pathogenesis of lung fibrosis. Molecular Aspects of Medicine 65: 56–69.PubMed
16.
Landi, C., E. Bargagli, A. Carleo, L. Bianchi, A. Gagliardi, A. Prasse, M.G. Perari, R.M. Refini, L. Bini, and P. Rottoli. 2014. A system biology study of BALF from patients affected by idiopathic pulmonary fibrosis (IPF) and healthy controls. Proteomics. Clinical Applications 8 (11–12): 932–950.PubMed
17.
Liu, X., and Z. Chen. 2017. The pathophysiological role of mitochondrial oxidative stress in lung diseases. Journal of Translational Medicine 15 (1): 207.PubMedPubMedCentral
18.
Liguori, I., G. Russo, F. Curcio, G. Bulli, L. Aran, D. Della-Morte, G. Gargiulo, G. Testa, F. Cacciatore, D. Bonaduce, and P. Abete. 2018. Oxidative stress, aging, and diseases. Clinical Interventions in Aging 13: 757–772.PubMedPubMedCentral
19.
Rottoli, P., B. Magi, R. Cianti, E. Bargagli, C. Vagaggini, N. Nikiforakis, V. Pallini, and L. Bini. 2005. Carbonylated proteins in bronchoalveolar lavage of patients with sarcoidosis, pulmonary fibrosis associated with systemic sclerosis and idiopathic pulmonary fibrosis. Proteomics 5 (10): 2612–2618.PubMed
20.
Bargagli, E., F. Penza, C. Vagaggini, B. Magi, M.G. Perari, and P. Rottoli. 2007. Analysis of carbonylated proteins in bronchoalveolar lavage of patients with diffuse lung diseases. Lung. 185 (3): 139–144.PubMed
21.
Malli, F., F. Bardaka, I. Tsilioni, E. Karetsi, K.I. Gourgoulianis, and Z. Daniil. 2013. 8-isoprostane levels in serum and bronchoalveolar lavage in idiopathic pulmonary fibrosis and sarcoidosis. Food and Chemical Toxicology 61: 160–163.PubMed
22.
Bargagli, E., F. Monaci, N. Bianchi, C. Bucci, and P. Rottoli. 2008. Analysis of trace elements in bronchoalveolar lavage of patients with diffuse lung diseases. Biological Trace Element Research 124 (3): 225–235.PubMed
23.
Bargagli, E., F. Lavorini, M. Pistolesi, E. Rosi, A. Prasse, E. Rota, and L. Voltolini. 2017. Trace metals in fluids lining the respiratory system of patients with idiopathic pulmonary fibrosis and diffuse lung diseases. Journal of Trace Elements in Medicine and Biology 42: 39–44.PubMed
24.
Sangiuolo, F., E. Puxeddu, G. Pezzuto, F. Cavalli, G. Longo, A. Comandini, D. di Pierro, M. Pallante, G. Sergiacomi, G. Simonetti, M. Zompatori, A. Orlandi, A. Magrini, M. Amicosante, F. Mariani, M. Losi, D. Fraboni, A. Bisetti, and C. Saltini. 2015. HFE gene variants and iron-induced oxygen radical generation in idiopathic pulmonary fibrosis. The European Respiratory Journal 45 (2): 483–490.PubMed
25.
Lee, J., I. Arisi, E. Puxeddu, L.K. Mramba, M. Amicosante, C.M. Swaisgood, M. Pallante, M.L. Brantly, C.M. Sköld, and C. Saltini. 2018. Bronchoalveolar lavage (BAL) cells in idiopathic pulmonary fibrosis express a complex pro-inflammatory, pro-repair, angiogenic activation pattern, likely associated with macrophage iron accumulation. PLoS One 13 (4): e0194803.PubMedPubMedCentral
26.
O'Dwyer, D.N., and B.B. Moore. 2019. Iron-ing out the roles of macrophages in idiopathic pulmonary fibrosis. American Journal of Respiratory and Critical Care Medicine.
27.
Ye, Q., Y. Dalavanga, N. Poulakis, S.U. Sixt, J. Guzman, and U. Costabel. 2008. Decreased expression of haem oxygenase-1 by alveolar macrophages in idiopathic pulmonary fibrosis. The European Respiratory Journal 31 (5): 1030–1036.PubMed
28.
Iwata, Y., M. Okamoto, T. Hoshino, Y. Kitasato, Y. Sakazaki, M. Tajiri, K. Matsunaga, K. Azuma, T. Kawayama, T. Kinoshita, H. Imaoka, K. Fujimoto, S. Kato, H. Yano, and H. Aizawa. 2010. Elevated levels of thioredoxin 1 in the lungs and sera of idiopathic pulmonary fibrosis, non-specific interstitial pneumonia and cryptogenic organizing pneumonia. Internal Medicine 49 (22): 2393–2400.PubMed
29.
Gorowiec, M.R., L.A. Borthwick, S.M. Parker, J.A. Kirby, G.C. Saretzki, and A.J. Fisher. 2012. Free radical generation induces epithelial-to-mesenchymal transition in lung epithelium via a TGF-ß1-dependent mechanism. Free Radical Biology & Medicine 52 (6): 1024–1032.
30.
Schamberger, A.C., H.B. Schiller, I.E. Fernandez, et al. 2016. Glutathione peroxidase 3 localizes to the epithelial lining fluid and the extracellular matrix in interstitial lung disease. Scientific Reports 6: 29952.PubMedPubMedCentral
31.
Hecker, L., R. Vittal, T. Jones, R. Jagirdar, T.R. Luckhardt, J.C. Horowitz, S. Pennathur, F.J. Martinez, and V.J. Thannickal. 2009. NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury. Nature Medicine 15: 1077–1081.PubMedPubMedCentral
32.
Watson, W.H., J.D. Ritzenthaler, and J. Roman. 2016. Lung extracellular matrix and redox regulation. Redox Biology 8: 305–315.PubMedPubMedCentral
33.
Hecker, L., N.J. Logsdon, D. Kurundkar, A. Kurundkar, K. Bernard, T. Hock, E. Meldrum, Y.Y. Sanders, and V.J. Thannickal. 2014. Reversal of persistent fibrosis in aging by targeting Nox4-Nrf2 redox imbalance. Science Translational Medicine 6: 231ra47.PubMedPubMedCentral
34.
Zhou, Y., X. Huang, L. Hecker, D. Kurundkar, A. Kurundkar, H. Liu, T.H. Jin, L. Desai, K. Bernard, and V.J. Thannickal. 2013. Inhibition of mechanosensitive signaling in myofibroblasts ameliorates experimental pulmonary fibrosis. The Journal of Clinical Investigation 123 (3): 1096–1108.PubMedPubMedCentral
35.
36.
Estany, S., V. Vicens-Zygmunt, R. Llatjós, A. Montes, R. Penín, I. Escobar, A. Xaubet, S. Santos, F. Manresa, J. Dorca, and M. Molina-Molina. 2014. Lung fibrotic tenascin-C upregulation is associated with other extracellular matrix proteins and induced by TGFβ1. BMC Pulmonary Medicine 14: 120.PubMedPubMedCentral
37.
Kliment, C.R., and T.D. Oury. 2010. Oxidative stress, extracellular matrix targets, and idiopathic pulmonary fibrosis. Free Radical Biology & Medicine 49 (5): 707–717.
38.
Chen, X., C. Shi, H. Cao, L. Chen, J. Hou, Z. Xiang, K. Hu, and X. Han. 2018. The hedgehog and Wnt/ß-catenin system machinery mediate myofibroblast differentiation of LR-MSCs in pulmonary fibrogenesis. Cell Death & Disease 9 (6): 639.
39.
Zeidler, P., A. Hubbs, L. Battelli, and V. Castranova. 2004. Role of inducible nitric oxide synthase-derived nitric oxide in silica-induced pulmonary inflammation and fibrosis. Journal of Toxicology and Environmental Health. Part A 67 (13): 1001–1026.PubMed
40.
Ricciardolo, F.L., P.J. Sterk, B. Gaston, and G. Folkerts. 2004. Nitric oxide in health and disease of the respiratory system. Physiological Reviews 84 (3): 731–765.PubMed
41.
Romanska, H.M., J.M. Polak, R.A. Coleman, R.S. James, D.W. Harmer, J.C. Allen, and A.E. Bishop. 2002. iNOS gene upregulation is associated with the early proliferative response of human lung fibroblasts to cytokine stimulation. The Journal of Pathology 197 (3): 372–379.PubMed
42.
Saleh, D., P.J. Barnes, and A. Giaid. 1997. Increased production of the potent oxidant peroxynitrite in the lungs of patients with idiopathic pulmonary fibrosis. American Journal of Respiratory and Critical Care Medicine 155 (5): 1763–1769.PubMed
43.
Hsu, Y.-C., L.-F. Wang, and Y.W. Chien. 2007. Nitric oxide in the pathogenesis of diffuse pulmonary fibrosis. Free Radical Biology & Medicine 42 (5): 599–607.
44.
Pullamsetti, S.S., R. Savai, R. Dumitrascu, B.K. Dahal, J. Wilhelm, M. Konigshoff, D. Zakrzewicz, and Ghofrani. 2011. The role of dimethylarginine dimethylaminohydrolase in idiopathic pulmonary fibrosis. Science Translational Medicine 3: 87ra53.PubMed
45.
Cameli, P., E. Bargagli, R.M. Refini, M.G. Pieroni, D. Bennett, and P. Rottoli. 2014. Exhaled nitric oxide in interstitial lung diseases. Respiratory Physiology & Neurobiology 197: 46–52.
46.
Cameli, P., E. Bargagli, and P. Rottoli. 2016. Exhaled nitric oxide is not increased in pulmonary sarcoidosis. Sarcoidosis, Vasculitis, and Diffuse Lung Diseases 33 (1): 39–40.PubMed
47.
Cameli, P., E. Bargagli, L. Bergantini, R.M. Refini, M. Pieroni, P. Sestini, and P. Rottoli. 2019. Evaluation of multiple-flows exhaled nitric oxide in idiopathic and non-idiopathic interstitial lung disease. Journal of Breath Research.
48.
Walters, D.M., H.Y. Cho, and S.R. Kleeberger. 2008. Oxidative stress and antioxidants in the pathogenesis of pulmonary fibrosis: a potential role for Nrf2. Antioxidants & Redox Signaling 10 (2): 321–332.
49.
Liu, Y., F. Lu, L. Kang, Z. Wang, and Y. Wang. 2017. Pirfenidone attenuates bleomycin-induced pulmonary fibrosis in mice by regulating Nrf2/Bach1 equilibrium. BMC Pulmonary Medicine 17 (1): 63.PubMedPubMedCentral
50.
Mazur, W., P. Lindholm, K. Vuorinen, et al. 2010. Cell-specific elevation of NRF2 and sulfiredoxin-1 as markers of oxidative stress in the lungs of idiopathic pulmonary fibrosis and non-specific interstitial pneumonia. APMIS 118 (9): 703–712.PubMed
51.
Carleo, A., E. Bargagli, C. Landi, D. Bennett, L. Bianchi, A. Gagliardi, C. Carnemolla, M.G. Perari, G. Cillis, A. Armini, L. Bini, and P. Rottoli. 2016. Comparative proteomic analysis of bronchoalveolar lavage of familial and sporadic cases of idiopathic pulmonary fibrosis. Journal of Breath Research 10 (2): 026007.PubMed
52.
Chilosi, M., A. Carloni, A. Rossi, and V. Poletti. 2013. Premature lung aging and cellular senescence in the pathogenesis of idiopathic pulmonary fibrosis and COPD/emphysema. Translational Research 162 (3): 156–173.PubMed
53.
Villegas, L., T. Stidham, and E. Nozik-Grayck. 2014. Oxidative stress and therapeutic development in lung diseases. Journal of Pulmonary & Respiratory Medicine 4 (4).
54.
Idiopathic Pulmonary Fibrosis Clinical Research Network, F.J. Martinez, J.A. de Andrade, K.J. Anstrom, T.E. King Jr., and G. Raghu. 2014. Randomized trial of acetylcysteine in idiopathic pulmonary fibrosis. The New England Journal of Medicine 370 (22): 2093–2101. https://​doi.​org/​10.​1056/​NEJMoa1401739.CrossRef
55.
Oldham, J.M., S.F. Ma, F.J. Martinez, et al. 2015. TOLLIP, MUC5B, and the response to N-Acetylcysteine among individuals with idiopathic pulmonary fibrosis. American Journal of Respiratory and Critical Care Medicine 192 (12): 1475–1482.PubMedPubMedCentral
Metadaten
Titel
Oxidant/Antioxidant Disequilibrium in Idiopathic Pulmonary Fibrosis Pathogenesis
verfasst von
Paolo Cameli
Alfonso Carleo
Laura Bergantini
Claudia Landi
Antje Prasse
Elena Bargagli
Publikationsdatum
11.07.2019
Verlag
Springer US
Erschienen in
Inflammation / Ausgabe 1/2020
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-019-01059-1

Weitere Artikel der Ausgabe 1/2020

Inflammation 1/2020 Zur Ausgabe

Original Article

Chloroquine and 3-Methyladenine Attenuates Periodontal Inflammation and Bone Loss in Experimental Periodontitis

Original Article

Piceatannol Inhibits P. acnes–Induced Keratinocyte Proliferation and Migration by Downregulating Oxidative Stress and the Inflammatory Response

Original Article

Cytomegalovirus Infection Exacerbates Experimental Colitis by Promoting IL-23 Production

Original Article

Visfatin Exerts Immunotherapeutic Effects in Lipopolysaccharide-Induced Acute Lung Injury in Murine Model

Review

The NLRP3 Inflammasome and Its Role in Sepsis Development

Original Article

Initial Immune Response in Escherichia coli, Staphylococcus aureus, and Candida albicans Bacteremia

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

19.04.2024 | Vorhofflimmern | Nachrichten

Parodontalbehandlung verbessert Prognose bei Katheterablation

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Prostatakarzinom: EU initiiert neues Screeningkonzept

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Blasenkarzinom – Biomarker statt Zytologie?

18.04.2024 | Arterielle Hypertonie | Nachrichten

Antihypertensiva schützen auch alte Menschen noch vor Demenz
weitere anzeigen

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise